CNE000001808
CNE000001808
TIANJIN PHARMACEUTICAL DA REN T
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 27.57B EUR | 28.66B EUR | 31.5B EUR | 35.13B EUR |
Enterprise Value | 24.13B EUR | 26.3B EUR | 30.65B EUR | 34.18B EUR |
Valuation Multiples | ||||
Trailing P/E | 32.25x | 45.96x | 16.1x | 18.43x |
Forward P/E | 19.78x | -- | -- | -- |
Price to Sales | 5.84x | 7.74x | 7.96x | 9.01x |
Price to Book | 4.64x | 4.82x | 4.19x | 4.95x |
EV/Revenue | 5.11x | 7.11x | 7.74x | 8.77x |
EV/EBITDA | 22.68x | 28.68x | 12.35x | 14.23x |
Price to FCF (P/FCF) | 18.71x | 46.86x | 93.97x | 134.64x |
EV/FCF | 16.38x | 43x | 91.45x | 131x |
FCF Yield | 5.34% | 2.13% | 1.06% | 0.74% |